David Hallal

Chairman & Chief Executive Officer

CEO CEO Board Member Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2020	Kalaris Therapeutics, Inc. (KLRS)	Chairman and Former Chief Executive Office r	$566,500	—	—	$14,277,568	$410,713	$3,805	$15,258,586
2019	Kalaris Therapeutics, Inc. (KLRS)	Chief Executive Officerand Chairman	$550,000	$5,000	$2,677,235	—	$330,000	$2,875	$3,565,110

Executive changes

Appointed Chief Executive Officer at Scholar Rock Holding Corp (SRRK)
2025-04-27
Appointed director (Audit Committee member) at Seer, Inc. (SEER)
2024-07-19

Earnings-call appearances

Canaccord Genuity 46th Annual Growth Conference
Scholar Rock Holding Corp (SRRK)

2026-08-12
Scholar Rock Q2 2026 Financial Results and Business Update Conference Call
Scholar Rock Holding Corp (SRRK)

2026-08-06
Goldman Sachs 47th Annual Global Healthcare Conference
Scholar Rock Holding Corp (SRRK)

2026-06-09
Jefferies Global 2026 Healthcare Conference
Scholar Rock Holding Corp (SRRK)

2026-06-03
Scholar Rock Holding Corp Q1 FY2026 Earnings Call
Scholar Rock Holding Corp (SRRK)

2026-05-07
Scholar Rock Holding Corp Q4 FY2025 Earnings Call
Scholar Rock Holding Corp (SRRK)

2026-03-03
Scholar Rock Holding Corp Q3 FY2025 Earnings Call
Scholar Rock Holding Corp (SRRK)

2025-11-14
Scholar Rock Holding Corp Q2 FY2025 Earnings Call
Scholar Rock Holding Corp (SRRK)

2025-08-06
Scholar Rock Holding Corp Q1 FY2025 Earnings Call
Scholar Rock Holding Corp (SRRK)

2025-05-14